Menu

Quaternium-15

Also known as: Quaternium 15

A formaldehyde-releasing preservative with a significant contact-allergy context and region-specific regulatory history.

Woodcut illustration of an amber jar and ceramic pot
Editorial illustration

Quaternium-15 is a formaldehyde-releasing preservative, not a generic name for all quaternary conditioning ingredients. It is relevant to contact dermatitis, especially with formaldehyde sensitization. The 2022 clinical review notes that its cosmetic use is forbidden in Europe; that regional restriction should not be mislabeled as a U.S. FDA rule.1, 2

  • A formaldehyde-releasing preservative.1, 2
  • Formaldehyde or the specific releaser can be relevant to allergy.1
  • The 2022 review describes an EU cosmetic prohibition, not a U.S. ban.1

What is Quaternium-15?

The quaternium numbering system does not mean all numbered ingredients have the same function or allergy profile. Quaternium-15's formaldehyde-releasing behavior is the important distinction here. Comparing it to a hair-conditioning trimonium solely because both names sound chemical loses that clinically relevant detail.2

Where it comes from

Natural sources

  • Not a botanical extract or a moisturizing nutrient.

How it's made

Manufactured formaldehyde donor used for preservation.

What it does in products

  • Microbial preservation

Benefits

Preserving a formulation

limited evidence

Its historical role is microbial preservation, not a direct skin benefit. An allergy history can make that preservative unsuitable for an individual.1, 2

The clinical review and government donor assessment explain hazard and allergy. They do not demonstrate that a quaternium-15 product improves a skin disease.

Evidence scope and limitations

Quaternium-15 preservative exposure and human contact allergy, with explicitly labeled European and Australian context.

  • No individual reaction probability or whole-product exposure estimate is made.
  • A non-U.S. restriction is not presented as an FDA rule.

Evidence last checked: 2026-10-01

Side effects & safety

Allergic contact dermatitis (varies)The diagnosis depends on relevant clinical history and testing, not an at-home guess from the ingredient name.

Safety considerations

  • Formaldehyde exposure depends on the product and release conditions; a label cannot calculate it precisely.
  • Not for: A diagnosed formaldehyde or quaternium-15 allergy warrants clinician-guided avoidance.
  • Not for: Substituting another formaldehyde releaser may not remove the relevant allergen exposure.
1, 2

Amounts studied & product use

These figures describe research or common product use, not a personal dose or treatment recommendation.

In skincare studies and products

No concentration recommendation is made. Diagnostic patch-test conditions and a hazard assessment are not a DIY preservative formula or a personal safe-use threshold.

2

Regulatory status

  • This U.S.-focused guide does not infer an FDA ban from European regulation. U.S. cosmetics remain subject to safety and labeling requirements; the cited review describes the EU prohibition.
  • INCI name on cosmetic labels: Quaternium-15.
3, 1

The number matters more than the family-sounding name

Quaternium-15 is not interchangeable with every ingredient containing quaternium or trimonium. A specific donor chemistry, use and allergy profile need their own assessment.

Regional regulation also needs its own label. A European prohibition, an Australian human-health assessment and U.S. cosmetic obligations are separate sources of information, not three versions of one rule.

1, 2, 3

Frequently asked questions

Are all quaterniums formaldehyde releasers?

The presence of quaternium in a name does not establish that behavior. This page concerns the specific preservative quaternium-15.2

Does its European status establish a U.S. ban?

No. A rule from one jurisdiction cannot be described as an FDA rule. The regional distinction is retained explicitly here.1, 3

The bottom line

Use the exact preservative identity, a confirmed allergy history and the correct jurisdiction when interpreting quaternium-15.

References

  1. Goossens A, Aerts O. Contact allergy to and allergic contact dermatitis from formaldehyde and formaldehyde releasers: A clinical review and update. Contact Dermatitis (2022) · other · PMID 35229319; DOI 10.1111/cod.14089
  2. Formaldehyde donors: Human health tier II assessment. Australian Industrial Chemicals Introduction Scheme (2020) · safety assessment
  3. FDA Authority Over Cosmetics: How Cosmetics Are Not FDA-Approved, but Are FDA-Regulated. U.S. Food and Drug Administration (2013) · government guidance · Page updated August 3, 2013; accessed October 1, 2026

Revision history

  1. Initial AI-assisted evidence compilation with source-linked claims, formulation distinctions and explicit research limitations; not independent medical review.